SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Simona Doniņa, Ieva Strēle, Guna Proboka, Jurgis Auziņš, Pēteris Alberts, Björn Jonsson, Dite Venskus, Aina Muceniece, Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective study, Melanoma Research, 2015, 25, 5, 421

    CrossRef

  2. 2
    Irene Palacios-Álvarez, Concepción Román-Curto, José M. Mir-Bonafé, Javier Cañueto, Teresa Usero-Bárcena, Emilia Fernández-López, Autoimmune response as a side effect of treatment with interferon-α in melanoma: does this have prognostic implications?, International Journal of Dermatology, 2015, 54, 3
  3. 3
    Ulla Feldt-Rasmussen, Increased risk of thyroid autoimmunity in rheumatoid arthritis, Endocrine, 2015, 50, 1, 4

    CrossRef

  4. 4
    M Buchert, C J Burns, M Ernst, Targeting JAK kinase in solid tumors: emerging opportunities and challenges, Oncogene, 2015,

    CrossRef

  5. 5
    Michail Kaklamanos, Dimitrios Thomas, Dimitrios Pikazis, Gregory Kaltsas, Thyroid-specific changes following treatment with biological therapies in patients with rheumatic diseases, Endocrine, 2015, 50, 1, 146

    CrossRef

  6. 6
    Geneviève Garcin, Franciane Paul, Markus Staufenbiel, Yann Bordat, José Van der Heyden, Stephan Wilmes, Guillaume Cartron, Florence Apparailly, Stefaan De Koker, Jacob Piehler, Jan Tavernier, Gilles Uzé, High efficiency cell-specific targeting of cytokine activity, Nature Communications, 2014, 5,

    CrossRef

  7. 7
    Chelsea Ma, April W Armstrong, Severe adverse events from the treatment of advanced melanoma: a systematic review of severe side effects associated with ipilimumab, vemurafenib, interferon alfa-2b, dacarbazine and interleukin-2, Journal of Dermatological Treatment, 2014, 25, 5, 401

    CrossRef

  8. 8
    Biotechnology in Medical Sciences, 2014,

    CrossRef

  9. 9
    Krista M. Rubin, Management of Primary Cutaneous and Metastatic Melanoma, Seminars in Oncology Nursing, 2013, 29, 3, 195

    CrossRef

  10. 10
    Robert H. I. Andtbacka, Matthew R. Donaldson, Tawnya L. Bowles, Glen M. Bowen, Kenneth Grossmann, Hung Khong, Douglas Grossman, Christopher Anker, Scott R. Florell, Anneli Bowen, Keith L. Duffy, Sancy A. Leachman, R. Dirk Noyes, Sentinel Lymph Node Biopsy for Melanoma in Pregnant Women, Annals of Surgical Oncology, 2013, 20, 2, 689

    CrossRef

  11. 11
    Howard L. Kaufman, John M. Kirkwood, F. Stephen Hodi, Sanjiv Agarwala, Thomas Amatruda, Steven D. Bines, Joseph I. Clark, Brendan Curti, Marc S. Ernstoff, Thomas Gajewski, Rene Gonzalez, Laura Jane Hyde, David Lawson, Michael Lotze, Jose Lutzky, Kim Margolin, David F. McDermott, Donald Morton, Anna Pavlick, Jon M. Richards, William Sharfman, Vernon K. Sondak, Jeffrey Sosman, Susan Steel, Ahmad Tarhini, John A. Thompson, Jill Titze, Walter Urba, Richard White, Michael B. Atkins, The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma, Nature Reviews Clinical Oncology, 2013, 10, 10, 588

    CrossRef

  12. 12
    Francesco Torino, Agnese Barnabei, Rosamaria Paragliola, Roberto Baldelli, Marialuisa Appetecchia, Salvatore Maria Corsello, Thyroid Dysfunction as an Unintended Side Effect of Anticancer Drugs, Thyroid, 2013, 23, 11, 1345

    CrossRef

  13. 13
    Sanjiv S Agarwala, An update on pegylated IFN-α2b for the adjuvant treatment of melanoma, Expert Review of Anticancer Therapy, 2012, 12, 11, 1449

    CrossRef

  14. 14
    Claus Garbe, Ketty Peris, Axel Hauschild, Philippe Saiag, Mark Middleton, Alan Spatz, Jean-Jacques Grob, Josep Malvehy, Julia Newton-Bishop, Alexander Stratigos, Hubert Pehamberger, Alexander M. Eggermont, Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2012, European Journal of Cancer, 2012, 48, 15, 2375

    CrossRef

  15. 15
    Adil Daud, Christopher Soon, Reinhard Dummer, Alexander MM Eggermont, Wen-Jen Hwu, Jean Jacques Grob, Claus Garbe, Axel Hauschild, Management of pegylated interferon alpha toxicity in adjuvant therapy of melanoma, Expert Opinion on Biological Therapy, 2012, 12, 8, 1087

    CrossRef

  16. 16
    Gregory K. Pennock, William Waterfield, Jedd D. Wolchok, Patient Responses to Ipilimumab, a Novel Immunopotentiator for Metastatic Melanoma, American Journal of Clinical Oncology, 2012, 35, 6, 606

    CrossRef

  17. 17
    Jennifer Rauw, Shaheeda Ahmed, Teresa Petrella, Pericardial effusion and tamponade following interferon alpha treatment for locally advanced melanoma, Medical Oncology, 2012, 29, 2, 1304

    CrossRef

  18. 18
    Krista M. Rubin, Karen Vona, Kathleen Madden, Suzanne McGettigan, Ilana M. Braun, Side effects in melanoma patients receiving adjuvant interferon alfa-2b therapy: a nurse’s perspective, Supportive Care in Cancer, 2012, 20, 8, 1601

    CrossRef

  19. 19
    Dorothée Nashan, Katrin Reuter, Peter Mohr, Sanjiv S. Agarwala, Understanding and managing interferon-α-related fatigue in patients with melanoma, Melanoma Research, 2012, 22, 6, 415

    CrossRef

  20. 20
    Aaron J Scott, Rodabe N Amaria, Karl Lewis, Adjuvant peginterferon alfa-2b therapy in stage III melanoma, Expert Review of Dermatology, 2011, 6, 6, 567

    CrossRef

  21. 21
    Achille Aouba, Sophie Georgin-Lavialle, Benjamin Terrier, Loïc Guillevin, François-Jérome Authier, Anti-PL7 antisynthetase syndrome under interferon therapy, Joint Bone Spine, 2011, 78, 1, 94

    CrossRef

  22. 22
    Katharina Frey, Andjelija Zivanovic, Kathrin Schwager, Dario Neri, Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation, Integrative Biology, 2011, 3, 4, 468

    CrossRef

  23. 23
    Blanca Ledezma, Sandra Binder, Omid Hamid, Atypical Clinical Response Patterns to Ipilimumab, Clinical Journal of Oncology Nursing, 2011, 15, 4, 393

    CrossRef

  24. 24
    Friederike Hoellen, Roland Reibke, Katrin Hornemann, Marc Thill, Doerte W. Luedders, Katharina Kelling, Amadeus Hornemann, Michael K. Bohlmann, Cancer in pregnancy. Part II: treatment options of breast and other non-gynecological malignancies, Archives of Gynecology and Obstetrics, 2011, 284, 6, 1481

    CrossRef

  25. 25
    Michal T. Krauze, Ahmad Tarhini, Helen Gogas, John M. Kirkwood, Prognostic significance of autoimmunity during treatment of melanoma with interferon, Seminars in Immunopathology, 2011, 33, 4, 385

    CrossRef

  26. 26
    Sergio Caravita, Maria Beatrice Secchi, Sheng Chin Wu, Simona Pierini, Anita Paggi, Sildenafil Therapy for Interferon-β-1a-Induced Pulmonary Arterial Hypertension: A Case Report, Cardiology, 2011, 120, 4, 187

    CrossRef

  27. 27
    Achille Aouba, Sophie Georgin-Lavialle, Benjamin Terrier, Loïc Guillevin, François-Jérome Authier, Syndrome des anti-synthétases anti-PL7 sous traitement par interféron, Revue du Rhumatisme, 2011, 78, 1, 85

    CrossRef

  28. 28
    M A Davies, Y Samuels, Analysis of the genome to personalize therapy for melanoma, Oncogene, 2010, 29, 41, 5545

    CrossRef

  29. 29
    Claus Garbe, Ketty Peris, Axel Hauschild, Philippe Saiag, Mark Middleton, Alain Spatz, Jean-Jacques Grob, Josep Malvehy, Julia Newton-Bishop, Alexander Stratigos, Hubert Pehamberger, Alexander Eggermont, Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline, European Journal of Cancer, 2010, 46, 2, 270

    CrossRef

  30. 30
    A. Aouba, S. Georgin-Lavialle, C. Pagnoux, N. Martin Silva, A. Renand, F. Galateau-Salle, S. Le Toquin, H. Bensadoun, F. Larousserie, S. Silvera, N. Provost, S. Candon, R. Seror, M. de Menthon, O. Hermine, L. Guillevin, B. Bienvenu, Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease, Blood, 2010, 116, 20, 4070

    CrossRef

  31. 31
    Jeremy Whelan, Daniel Patterson, Martha Perisoglou, Stefan Bielack, Neyssa Marina, Sigbjorn Smeland, Mark Bernstein, The role of interferons in the treatment of osteosarcoma, Pediatric Blood & Cancer, 2010, 54, 3
  32. 32
    Susan M. Swetter, Mohammed Kashani-Sabet, Peter Johannet, Sunil A. Reddy, Theodore Locke Phillips, Leibel and Phillips Textbook of Radiation Oncology, 2010,

    CrossRef

  33. 33
    Camillo Porta, Cezary Szczylik, Tolerability of first-line therapy for metastatic renal cell carcinoma, Cancer Treatment Reviews, 2009, 35, 3, 297

    CrossRef

  34. 34
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2008, 17, 9
  35. 35
    Patrick Terheyden, Wolfgang Tilgen, Axel Hauschild, Recent aspects of medical care of malignant melanoma, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2008, 6, 10
  36. 36
    Sunanda Sadanandan, Timothy Hurley, Carolyn Muller, Claire Verschraegen, Marianne Berwick, Charles L. Wiggins, Kimberly K. Leslie, Cancer in Pregnancy,
  37. 37
    Simone Mocellin, Marko B Lens, Sandro Pasquali, Pierluigi Pilati, Vanna Chiarion Sileni, Interferon alpha for the adjuvant treatment of cutaneous melanoma, The Cochrane Library,